CENTRAL PHARMA CELL AND GENE THERAPY LTD
Company number 12769240
- Company Overview for CENTRAL PHARMA CELL AND GENE THERAPY LTD (12769240)
- Filing history for CENTRAL PHARMA CELL AND GENE THERAPY LTD (12769240)
- People for CENTRAL PHARMA CELL AND GENE THERAPY LTD (12769240)
- More for CENTRAL PHARMA CELL AND GENE THERAPY LTD (12769240)
| Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
|---|---|---|---|
| 14 Nov 2024 | AA | Accounts for a small company made up to 31 December 2023 | |
| 21 Jan 2024 | CS01 | Confirmation statement made on 4 January 2024 with no updates | |
| 13 Nov 2023 | AA | Audit exemption subsidiary accounts made up to 31 December 2022 | |
| 13 Nov 2023 | PARENT_ACC | Consolidated accounts of parent company for subsidiary company period ending 31/12/22 | |
| 11 Oct 2023 | GUARANTEE2 | Audit exemption statement of guarantee by parent company for period ending 31/12/22 | |
| 11 Oct 2023 | AGREEMENT2 | Notice of agreement to exemption from audit of accounts for period ending 31/12/22 | |
| 02 Mar 2023 | AA | Accounts for a small company made up to 31 December 2021 | |
| 26 Jan 2023 | CS01 | Confirmation statement made on 4 January 2023 with no updates | |
| 15 Nov 2022 | DISS40 | Compulsory strike-off action has been discontinued | |
| 25 Oct 2022 | GAZ1 | First Gazette notice for compulsory strike-off | |
| 01 Apr 2022 | AA01 | Previous accounting period extended from 31 July 2021 to 31 December 2021 | |
| 01 Apr 2022 | CS01 | Confirmation statement made on 4 January 2022 with no updates | |
| 13 Oct 2021 | DISS40 | Compulsory strike-off action has been discontinued | |
| 12 Oct 2021 | CS01 | Confirmation statement made on 26 July 2021 with no updates | |
| 12 Oct 2021 | GAZ1 | First Gazette notice for compulsory strike-off | |
| 27 Jul 2020 | NEWINC |
Incorporation
Statement of capital on 2020-07-27
|